Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion type Assertion NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_head.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion description "[Overexpression of p53, normally secondary to gene mutation, in invasive uroepithelial neoplasms (transitional cell carcinoma) and a high percentage of transitional cell carcinoma in situ (CIS) has been described; however, the role of p53 before and after bacillus Calmette-Gu�rin (BCG) treatment of CIS needs to be defined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_provenance.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion evidence source_evidence_literature NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_provenance.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion SIO_000772 9111623 NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_provenance.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion wasDerivedFrom befree-20140225 NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_provenance.
- NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_assertion wasGeneratedBy ECO_0000203 NP542485.RAeA5upNkA_X5L86Uo3bD9lj4cgh8LHD_Uitwu99QkY00130_provenance.